Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Mayu Tochiya"'
Autor:
Yu Kataoka, Satoshi Kitahara, Sayaka Funabashi, Hisashi Makino, Masaki Matsubara, Miki Matsuo, Yoko Omura-Ohata, Ryo Koezuka, Mayu Tochiya, Tamiko Tamanaha, Tsutomu Tomita, Kyoko Honda-Kohmo, Michio Noguchi, Kota Murai, Kenichiro Sawada, Takamasa Iwai, Hideo Matama, Satoshi Honda, Masashi Fujino, Kazuhiro Nakao, Shuichi Yoneda, Kensuke Takagi, Fumiyuki Otsuka, Yasuhide Asaumi, Kiminori Hosoda, Stephen J. Nicholls, Satoshi Yasuda, Teruo Noguchi
Publikováno v:
Atherosclerosis Plus, Vol 56, Iss , Pp 1-6 (2024)
Background and aims: Randomized clinical trials have demonstrated the ability of glucagon-like peptide-1 analogues (GLP-1RAs) to reduce atherosclerotic cardiovascular disease events in patients with type 2 diabetes (T2D). How GLP-1RAs modulate diabet
Externí odkaz:
https://doaj.org/article/409a421a06d648bab589ebcb9fd6fd88
Autor:
Mayu Tochiya, Hisashi Makino, Tamiko Tamanaha, Yoko Omura‐Ohata, Masaki Matsubara, Ryo Koezuka, Michio Noguchi, Tsutomu Tomita, Yasuhide Asaumi, Yoshihiro Miyamoto, Satoshi Yasuda, Kiminori Hosoda
Publikováno v:
ESC Heart Failure, Vol 10, Iss 2, Pp 1158-1169 (2023)
Abstract Aims The relationship between diabetic microvascular complications and the incidence of two types of heart failure—heart failure with reduced ejection fraction (HFrEF) (left ventricular ejection fraction [LVEF]
Externí odkaz:
https://doaj.org/article/0c5851a531b24346b0288d48f1fe6f56
Autor:
Mayu Tochiya, Hisashi Makino, Tamiko Tamanaha, Miki Matsuo, Ai Hishida, Ryo Koezuka, Yoko Ohata, Tsutomu Tomita, Choel Son, Yoshihiro Miyamoto, Satoshi Yasuda, Kiminori Hosoda
Publikováno v:
Journal of Diabetes Investigation, Vol 11, Iss 2, Pp 400-404 (2020)
Abstract Recent studies have shown that sodium–glucose cotransporter 2 inhibitors decrease the risk of heart failure in patients with type 2 diabetes. However, the precise mechanisms of action of these drugs are not well understood. In the present
Externí odkaz:
https://doaj.org/article/f6b8db34ccca4270b798ea76b031b24e
Autor:
Yoko Omura-Ohata, Cheol Son, Hisashi Makino, Ryo Koezuka, Mayu Tochiya, Tamiko Tamanaha, Ichiro Kishimoto, Kiminori Hosoda
Publikováno v:
Cardiovascular Diabetology, Vol 18, Iss 1, Pp 1-8 (2019)
Abstract Background Visceral fat area (VFA) is a good surrogate marker of obesity-related disorders, such as hypertension, dyslipidemia and glucose intolerance. Although estimating the VFA by X-ray computed tomography (CT) is the primary index for vi
Externí odkaz:
https://doaj.org/article/abac68cd722f47c38163a96cd2e5819e
Autor:
Hisashi Makino, J Kobayashi, Y Miyamoto, T Tamanaha, Yoko Ohata, Mayu Tochiya, Y Shimabara, C Son, T Fujita, A Tanaka, K Asakura, K Hosoda, R Koezuka
Publikováno v:
Diabetic Medicine. 36:1621-1628
AIM To test the hypothesis that the addition of a glucagon-like peptide-1 receptor agonist that can decrease glucose levels without increasing the hypoglycaemia risk will achieve appropriate glycaemic control during the peri-operative period. METHODS
Autor:
Tsutomu Tomita, Kiminori Hosoda, Satoshi Yasuda, Choel Son, Ai Hishida, Ryo Koezuka, Yoko Ohata, Yoshihiro Miyamoto, Hisashi Makino, Miki Matsuo, Mayu Tochiya, Tamiko Tamanaha
Publikováno v:
Journal of Diabetes Investigation
Journal of Diabetes Investigation, Vol 11, Iss 2, Pp 400-404 (2020)
Journal of Diabetes Investigation, Vol 11, Iss 2, Pp 400-404 (2020)
Recent studies have shown that sodium–glucose cotransporter 2 inhibitors decrease the risk of heart failure in patients with type 2 diabetes. However, the precise mechanisms of action of these drugs are not well understood. In the present study, we
Autor:
Yoshihiro Miyamoto, Hisashi Makino, Ai Hishida, Ryo Koezuka, Kiminori Hosoda, Miki Matsuo, Yoko Ohata, Cheol Son, Tamiko Tamanaha, Mayu Tochiya
Publikováno v:
Diabetology International. 10:148-152
BACKGROUND: Dipeptidyl peptidase-4 (DPP-4) inhibitors are commonly used for the treatment of type 2 diabetes and have been previously shown to prevent diabetic renal injury via various mechanisms, including the attenuation of oxidative stress. Theref
Autor:
Hisashi Makino, Yoko Omura-Ohata, Kiminori Hosoda, Ichiro Kishimoto, Ryo Koezuka, Mayu Tochiya, Cheol Son, Tamiko Tamanaha
Publikováno v:
Cardiovascular Diabetology
Cardiovascular Diabetology, Vol 18, Iss 1, Pp 1-8 (2019)
Cardiovascular Diabetology, Vol 18, Iss 1, Pp 1-8 (2019)
Background Visceral fat area (VFA) is a good surrogate marker of obesity-related disorders, such as hypertension, dyslipidemia and glucose intolerance. Although estimating the VFA by X-ray computed tomography (CT) is the primary index for visceral ob
Autor:
Hisashi Makino, Satoshi Yasuda, T Tamanaha, Yoko Ohata, K. Minematsu, Toshihisa Anzai, Kazunori Toyoda, Ichiro Kishimoto, Kengo Kusano, Mayu Tochiya, Hisao Ogawa
Publikováno v:
Diabetic Medicine. 33:1118-1124
Aims To examine if a simple biomarker can identify people with diabetes who are at high risk of atrial fibrillation. Methods A retrospective cohort study was conducted at a single centre in people with Type 2 diabetes referred to our department betwe
Autor:
Masaya Miyazono, Yasuko Hagiwara, Masayo Yamamoto, Ichiro Kishimoto, Hisashi Makino, Mayu Tochiya, Tamiko Tamanaha, Yoko Ohata, Toshiaki Fujimoto, Yoko Omori, Keiko Iinuma, Yasuhiro Ashida, Kazue Maeda, Hirotoshi Nishi
Publikováno v:
Diabetology International. 6:117-124
A questionnaire survey was conducted at local pharmacies in an urban area to investigate awareness and management of cardiovascular risk factors in patients with diabetes. Among respondents, 51, 86, and 94 % stated that they knew their low density li